Oakland, United States
Fabric Genomics, now part of GeneDx, is pushing the boundaries of precision medicine by making genomics-driven care faster and more accessible. Founded in 2009 and headquartered in the United States, Fabric Genomics operates in key industries such as AI, Biotechnology, and Health Care.
Their core offering includes an AI-driven decision support software that empowers clinical labs and hospital systems to convert complex genomic data into actionable clinical insights. This assists physicians in making quicker, more accurate diagnoses, particularly in rare disease diagnosis and hereditary risk assessments.
The company's cutting-edge platform efficiently interprets whole genomes, exomes, and gene panels, underpinning timely clinical decision-making. Additionally, their CLIA- and CAP-accredited services provide expert reporting support, appealing to labs seeking expansion without in-house genetics expertise.
Supported by a Venture Round investment in May 2021 by Mighty Capital, Fabric Genomics is positioned as a trusted partner to leading global institutions, merging the capabilities of AI and genomics at the forefront of patient care.
